Endonovo Therapeutics, Inc. (ENDV)

USD 0.0

(0.0%)

Revenue Summary of Endonovo Therapeutics, Inc.

  • Endonovo Therapeutics, Inc.'s latest annual revenue in 2023 was 140.24 Thousand USD , up 3.61% from previous year.
  • Endonovo Therapeutics, Inc.'s latest quarterly revenue in 2024 Q2 was 1661.00 USD , down -80.18% from previous quarter.
  • Endonovo Therapeutics, Inc. reported a annual revenue of 135.35 Thousand USD in annual revenue 2022, up 85.15% from previous year.
  • Endonovo Therapeutics, Inc. reported a annual revenue of 73.1 Thousand USD in annual revenue 2021, down -55.91% from previous year.
  • Endonovo Therapeutics, Inc. reported a quarterly revenue of 8382.00 USD for 2024 Q1, up 40.12% from previous quarter.
  • Endonovo Therapeutics, Inc. reported a quarterly revenue of 5982.00 USD for 2023 Q4, up 293.55% from previous quarter.

Annual Revenue Chart of Endonovo Therapeutics, Inc. (2023 - 2009)

Historical Annual Revenue of Endonovo Therapeutics, Inc. (2023 - 2009)

Year Revenue Revenue Growth
2023 140.24 Thousand USD 3.61%
2022 135.35 Thousand USD 85.15%
2021 73.1 Thousand USD -55.91%
2020 165.79 Thousand USD -46.55%
2019 310.16 Thousand USD 272.51%
2018 83.26 Thousand USD 0.0%
2017 - USD 0.0%
2016 - USD -100.0%
2015 4265.00 USD -82.37%
2014 24.19 Thousand USD 5.66%
2013 22.89 Thousand USD -25.13%
2012 30.58 Thousand USD -35.98%
2011 47.76 Thousand USD -21.16%
2010 60.58 Thousand USD 0.98%
2009 60 Thousand USD 0.0%

Peer Revenue Comparison of Endonovo Therapeutics, Inc.

Name Revenue Revenue Difference
Burzynski Research Institute, Inc. - USD -Infinity%
Arch Therapeutics, Inc. 75.72 Thousand USD -85.202%
Evofem Biosciences, Inc. 18.21 Million USD 99.23%
Nascent Biotech, Inc. - USD -Infinity%
Rebus Holdings, Inc. - USD -Infinity%
Santhera Pharmaceuticals Holding AG 122.95 Million USD 99.886%
Qrons Inc. - USD -Infinity%
Adynxx, Inc. - USD -Infinity%
Neon Bloom, Inc. - USD -Infinity%
Northwest Biotherapeutics, Inc. 1.93 Million USD 92.741%
ProtoKinetix, Incorporated - USD -Infinity%
Skye Bioscience, Inc. - USD -Infinity%
Eiger BioPharmaceuticals, Inc. 15.77 Million USD 99.111%
Nanobac Pharmaceuticals, Incorporated 17.62 Thousand USD -695.88%
Institute of Biomedical Research Corp. - USD -Infinity%
SQZ Biotechnologies Company 21.47 Million USD 99.347%
Intellipharmaceutics International Inc. 65.72 Thousand USD -113.367%
Propanc Biopharma, Inc. - USD -Infinity%
Mesoblast Limited 5.9 Million USD 97.624%
Marizyme, Inc. 645.81 Thousand USD 78.284%
Genus plc 668.8 Million USD 99.979%
VioQuest Pharmaceuticals, Inc. - USD -Infinity%
Pharming Group N.V. 245.31 Million USD 99.943%
Therapeutic Solutions International, Inc. 98.99 Thousand USD -41.667%
CNBX Pharmaceuticals Inc. 410.16 Thousand USD 65.808%
Nymox Pharmaceutical Corporation - USD -Infinity%
ContraFect Corporation - USD -Infinity%
PsyBio Therapeutics Corp. - USD -Infinity%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
RegeneRx Biopharmaceuticals, Inc. 76.76 Thousand USD -82.7%
IMV Inc. - USD -Infinity%
AXIM Biotechnologies, Inc. 39.51 Thousand USD -254.881%
MultiCell Technologies, Inc. 49.32 USD -284251.176%
ONE Bio Corp. 52.29 Million USD 99.732%
Accustem Sciences Inc. - USD -Infinity%
RVL Pharmaceuticals plc 49.72 Million USD 99.718%
Arno Therapeutics, Inc. - USD -Infinity%
EV Biologics, Inc. 48.9 Thousand USD -186.793%
Q BioMed Inc. 284.35 Thousand USD 50.68%
Emmaus Life Sciences, Inc. 29.59 Million USD 99.526%
Mosaic ImmunoEngineering Inc. - USD -Infinity%
Biomind Labs Inc. - USD -Infinity%
American Oriental Bioengineering, Inc. 145.09 Million USD 99.903%
Provectus Biopharmaceuticals, Inc. 557.71 Thousand USD 74.854%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
Oncotelic Therapeutics, Inc. 70 Thousand USD -100.346%
GlobeStar Therapeutics Corporation - USD -Infinity%
THC Farmaceuticals, Inc. - USD -Infinity%
Acro Biomedical Co., Ltd. 658.5 Thousand USD 78.703%
Curative Biotechnology, Inc. - USD -Infinity%
GB Sciences, Inc. - USD -Infinity%
Alpha Cognition Inc. - USD -Infinity%
HST Global, Inc. - USD -Infinity%
CSL Limited 14.69 Billion USD 99.999%
Wesana Health Holdings Inc. - USD -Infinity%
Halberd Corporation 999.00 USD -13938.238%
Enzolytics Inc. 52.79 Thousand USD -165.63%
Agentix Corp. - USD -Infinity%
Resverlogix Corp. - USD -Infinity%
Nuo Therapeutics, Inc. 608.52 Thousand USD 76.954%
MetaStat, Inc. - USD -Infinity%
argenx SE 1.22 Billion USD 99.989%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
RespireRx Pharmaceuticals Inc. - USD -Infinity%
GeneThera, Inc. - USD -Infinity%
Inhibitor Therapeutics, Inc. - USD -Infinity%
AVAX Technologies, Inc. 617.38 Thousand USD 77.284%
Zenith Capital Corp. - USD -Infinity%
Genscript Biotech Corporation 839.52 Million USD 99.983%
Ember Therapeutics, Inc. - USD -Infinity%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. - USD -Infinity%
WPD Pharmaceuticals Inc. - USD -Infinity%
Cotinga Pharmaceuticals Inc. - USD -Infinity%
Kadimastem Ltd - USD -Infinity%
Helix BioMedix, Inc. 997.72 Thousand USD 85.944%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
Capstone Therapeutics Corp. 48.35 Million USD 99.71%
BioStem Technologies, Inc. 16.68 Million USD 99.159%
Oncology Pharma Inc. - USD -Infinity%
Reve Technologies, Inc. - USD -Infinity%
LadRx Corporation - USD -Infinity%
Cell Source, Inc. - USD -Infinity%
Regen BioPharma, Inc. 236.56 Thousand USD 40.716%
Regen BioPharma, Inc. 236.56 Thousand USD 40.716%
NovAccess Global Inc. - USD -Infinity%
Affymax, Inc. 1.36 Million USD 89.756%
Itoco Inc. - USD -Infinity%
Rasna Therapeutics, Inc. - USD -Infinity%
Pathfinder Cell Therapy, Inc. - USD -Infinity%
Mobile Lads Corp. - USD -Infinity%
CytoDyn Inc. - USD -Infinity%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
NanoSphere Health Sciences Inc. - USD -Infinity%
Alseres Pharmaceuticals, Inc. 473.73 Thousand USD 70.396%
SYBLEU INC 11.69 Thousand USD -1099.06%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
ImmunoCellular Therapeutics, Ltd. - USD -Infinity%
International Stem Cell Corporation 7.78 Million USD 98.199%
Bioxytran, Inc. - USD -Infinity%
GlobeImmune, Inc. - USD -Infinity%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. - USD -Infinity%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. - USD -Infinity%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. 13 Thousand USD -978.785%
Adhera Therapeutics, Inc. - USD -Infinity%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. - USD -Infinity%
Innovation Pharmaceuticals Inc. - USD -Infinity%
Neutra Corp. 39.53 Thousand USD -254.738%
Windtree Therapeutics, Inc. - USD -Infinity%
PureTech Health plc 3.33 Million USD 95.789%
Coeptis Therapeutics, Inc. - USD -Infinity%
IXICO plc 6.66 Million USD 97.896%
IntelGenx Technologies Corp. 1.03 Million USD 86.502%
Gelesis Holdings, Inc. 25.76 Million USD 99.456%
CSL Limited 14.8 Billion USD 99.999%
Cellectis S.A. 755 Thousand USD 81.425%